Skip to content
Search

Latest Stories

Diabetes drug prescriptions rises eight million since 2015, NHS report says

Nearly 60 million drugs were used to treat people with diabetes in England last year, increasing eight million since 2015-16, a report by the NHS revealed.

The latest data released by the NHS Business Service Authority (NHSBSA) showed that 57.9 million drugs were prescribed during 2020-21, costing the exchequer £1.19 billion. It accounted for 12.5 per cent of the total spend on all prescription items.


The data showed a steep increase from 2015-16, where 49.7 million diabetes items were prescribed for a cost of £958 million, accounting for 10.4 per cent of the total spend.

The study entitled ‘Prescribing for diabetes England 2015-2016 to 2020-2021’, also found that there were over 3.05 million identified patients, who were prescribed diabetes drugs, against 3 million patients in 2019-20, and 2.70 million in 2015-16.

It further revealed that most people who were prescribed drugs for diabetes last year lived in deprived areas.

The most common age group among the patients in 2020-21 was 70 to 74, higher than 65 to 69 registered in 2015-16.

Besides, cost of antidiabetic drugs increased by 62 per cent from £423m in 2015-16 to £686m last year.

In 2020-21, 43.1 million antidiabetic drug items were prescribed.

The most deprived areas in England have the highest number of identified patients being prescribed drugs used in treating diabetes in 2020-21.

More For You

Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less
Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less